Secukinumab treatment in spondyloarthritis: Retention rate and effectiveness data at 12 months – data from the Romanian Registry of Rheumatic Diseases

Background. Registries data are important contributors to complement information provided by randomized controlled trial reports in terms of effectiveness and safety evaluation for anti-rheumatic drugs used in clinical practice. Objectives. We aimed to estimate the 12 month secukinumab retention ra...

Full description

Bibliographic Details
Main Authors: Corina Mogosan, Ruxandra Ionescu, Simona Rednic, Magda Parvu, Elena Rezus, Catalin Codreanu
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2020-12-01
Series:Romanian Journal of Rheumatology
Subjects:
Online Access:https://rjr.com.ro/articles/2020.4/RJR_2020_4_Art-02.pdf